Dive Summary:
- Nestle just announce it has boughtPamlab, a Louisiana-based food company that makes vitamin rich supplements that help battle depression.
- This is the second medical food company that Nestle has bought in the past eight months under its subsidiary, Nestle Health Sciences.
- NHS is focusing on prescription based nutritional therapy, an industry it believes will see excellent growth in the years to come.
From the article:
The undisclosed buy followsNestléHealth Science’s (NHS) July 2012 investment inAccera, the US firm behindAxona, anotherpharma-food(phood) targeted at people with mild to moderate Alzheimer’s.
Nestlé发言人希拉里绿色告诉我们Pamlabwill not be integrated withAccera, that it would, "continue to
operate as a stand-alone business within theNestléHealth Science company, and itsorganisationalstructure won’t change."
